<code id='5A4574E122'></code><style id='5A4574E122'></style>
    • <acronym id='5A4574E122'></acronym>
      <center id='5A4574E122'><center id='5A4574E122'><tfoot id='5A4574E122'></tfoot></center><abbr id='5A4574E122'><dir id='5A4574E122'><tfoot id='5A4574E122'></tfoot><noframes id='5A4574E122'>

    • <optgroup id='5A4574E122'><strike id='5A4574E122'><sup id='5A4574E122'></sup></strike><code id='5A4574E122'></code></optgroup>
        1. <b id='5A4574E122'><label id='5A4574E122'><select id='5A4574E122'><dt id='5A4574E122'><span id='5A4574E122'></span></dt></select></label></b><u id='5A4574E122'></u>
          <i id='5A4574E122'><strike id='5A4574E122'><tt id='5A4574E122'><pre id='5A4574E122'></pre></tt></strike></i>

          knowledge

          knowledge

          author:knowledge    Page View:14
          People taking notes while sitting around a meeting table
          Adobe

          It makes sense in theory for hospitals and startups to strike deals. Not only would doctors get first dibs on new health care technologies, their organizations would see windfalls if those startups hit it big.

          In practice, it often doesn’t work out that way. Doctors and other clinicians have their own way of doing things, and they typically don’t take kindly to an administrator telling them to learn a new product, especially if the goal is financial gain.

          advertisement

          Several health system-venture capital arrangements have fallen victim to this dynamic — but VC firm General Catalyst said this week it will buy nonprofit Summa Health, anyway.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Cassava reveals details — and problems — with Alzheimer's study
          Cassava reveals details — and problems — with Alzheimer's study

          MollyFerguson/STATCassavaScienceshaslongclaimeditsexperimentaldrug,calledsimufilam,slowsthecognitive

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          First Opinion on colorectal cancer screening: letter and response

          MollyFergusonforSTATToencouragerobust,good-faithdiscussionaboutdifficultissues,STATpublishesselected